VIM and head and neck squamous cell carcinoma: Unexpectedly, the overall survival rate of HNSCC patients (n = 519) with high expression of Vimentin (n = 354), the most common mesenchymal-related marker, was not different from that of HNSCC patients with low expression of Vimentin (n = 145) (Fig. 1d).